Ann: Proposed in-specie distribution - Update, page-2

Yeh I never saw how they could do the inspecie distribution and get another investment of equal or better value in time for re-listing (which would be required to maintain their PDF status). If I was the director, there would be no way I would want to distribute my assets and potentially lose the PDF status. They can only suspend for 2 years, so they were running out of time. But now that Breeze is the director, he doesn't need the in-specie distribution. It is good news since it will play out just like 2010, this time BPH has even more invested in Advent with a almost guaranteed FDA approval on the horizon.

The only part I don't understand is that they will pay back what they owe to Advent. How? Will it back like a loan, and maybe give MMR shares to Advent before the drill like previous loans?